Similar Posts
Hopping Mad Over Drug Company Product Hopping
Byadmin2The state of California is suing Gilead Sciences over its delay of an HIV drug, a move that critics of the pharmaceutical industry call “product hopping.” Regardless of how the lawsuit comes out, the company’s actions strike me as deeply immoral and ought to leave all of us hopping mad. Here’s what we know.
Federalizing Medicaid
Byadmin
Here is a new post I’ve got up at the Health Care Cost Monitor, in which I try to convince folks that even Republicans should be in favor of federalizing Medicaid. I’d love your feedback, as I’m still developing this idea.Life or quality of life — what matters to oncologists?
ByadminTake a look at a brief summary of a new paper i just published, led by a wonderful medical student at Michigan, Michael Kozminski. It shows that oncologists seem to place far greater value on quantity of life over quality of life.
Feeling Conflicted about Greed
ByadminWith jobs disappearing faster than a major league fastball, the public is understandably irate at the damage that greed has wrought upon our economy. Financiers destroy their companies, and our retirement portfolios, and then complain when their bonuses are less than 7 figures. The greedy behavior in recent headlines has not been limited to Wall…
Autonomy, paternalism and understanding
ByadminI gave a talk Wednesday as part of an ethics series here at Duke. Here is one take on my presentation. See if you can spot the Far Side reference!
New podcast on research ethics and stubbornness
ByadminCheck out my latest podcast, which accompanies a new article I co-authored with Robert Silbergleit. In the article, and in the podcast, I discuss a problem plaguing clinical research: that doctors are sometimes not convinced by previous research, and thus want to see more evidence before changing their practice, but at the same time experts,…
